Univet Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 89.76%
- Profit Growth 165.14%
- Ebitda 144.53%
- Net Worth 5.05%
- Total Assets -16.31%
About Univet Pharmachem
Univet Pharmachem Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2012 and has a history of 12 years and nine months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raju Pundir, Barkha Pundir, and Sneha Pundir serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2012PTC028280
-
Company No.
028280
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Univet Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raju Pundir
|
Director | 25-Apr-2012 | Current |
|
Barkha Pundir
|
Director | 25-Apr-2012 | Current |
|
Sneha Pundir
|
Director | 25-Apr-2012 | Current |
Financial Performance of Univet Pharmachem.
Univet Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 89.76% increase. The company also saw a substantial improvement in profitability, with a 165.14% increase in profit. The company's net worth moved up by a moderate rise of 5.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Univet Pharmachem?
In 2017, Univet Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Benison Farm Vet Private LimitedRaju Pundir and Sneha Pundir are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Univet Pharmachem?
Unlock and access historical data on people associated with Univet Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Univet Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Univet Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.